Biotech Values

[DewDiligence]

HALO borrows additional $20M from banks:

http://www.sec.gov/Archives/edgar/data/1159036/000115903614000002/a8-k_halo27dec2013.htm

On December 27, 2013, Halozyme Therapeutics, Inc…entered into an Amended and Restated Loan and Security Agreement with Oxford Finance LLC…and Silicon Valley Bank...

The Original Loan Agreement provided for a $30 million secured single-draw term loan facility with a maturity date of January 1, 2017. The original term loan was fully drawn at close [in Dec 2012].

The [amended] Loan Agreement extends the original $30 million term loans and provides for an additional $20 million in new term loans, bringing the total term loan balance to $50 million. Upon closing of the Loan Agreement, the Company received approximately $19 million, net of accrued interest.